Company Profile

Cash Flow

MANKIND PHARMA LTD.

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private

BSE2368.00-13.95 (-0.59 %)

PREV CLOSE ( ) 2381.95

OPEN PRICE ( ) 2372.15

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 6420

TODAY'S LOW / HIGH ( )2336.55 2384.25

52 WK LOW / HIGH ( )1910.1 3050

NSE2370.00-11.3 (-0.47 %)

PREV CLOSE( ) 2381.30

OPEN PRICE ( ) 2380.00

BID PRICE (QTY) 2370.00 (126)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 251064

TODAY'S LOW / HIGH( ) 2336.40 2383.70

52 WK LOW / HIGH ( )1901.05 3054.8

Particulars

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Profit Before Tax

23993.58

16712.39

19746.01

16916.11

14377.35

Adjustment

2122.05

2984.30

308.07

-56.59

1054.57

Changes In working Capital

204.16

1667.29

-5861.21

-946.33

-1400.77

Cash Flow after changes in Working Capital

26319.79

21363.98

14192.87

15913.19

14031.16

Cash Flow from Operating Activities

21524.45

18133.02

9197.79

11372.44

10722.04

Cash Flow from Investing Activities

-20816.90

-10541.29

-13691.44

-12222.11

-4391.54

Cash Flow from Financing Activities

52.66

-7397.28

6046.21

-78.11

-5269.69

Net Cash Inflow / Outflow

760.20

194.45

1552.55

-927.78

1060.82

Opening Cash & Cash Equivalents

3048.21

2830.60

1273.27

2197.31

1163.90

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

11.67

23.15

4.78

3.75

36.04

Closing Cash & Cash Equivalent

3820.08

3048.21

2830.60

1273.28

2260.75